Santhera Pharmaceuticals Holding Ltd. header image

Santhera Pharmaceuticals Holding Ltd.

SANN

Equity

ISIN CH1276028821 / Valor 127602882

SIX Swiss Exchange (2026-10-02)

CHF 15.12-0.40%

Santhera Pharmaceuticals Holding Ltd.
UMushroom community rating:

5.00 1 votes No rating yet

NegativeNeutralPositive

About company

Santhera Pharmaceuticals Holding Ltd. is a Swiss specialty pharmaceutical company that develops and commercializes therapies for rare neuromuscular, mitochondrial and related pulmonary disorders. Its work has centered on orphan-drug programs — most prominently formulations of idebenone (marketed in some indications) — and clinical development efforts in Duchenne muscular dystrophy and other rare disease indications. The company operates as a typical small-cap biotech, generating revenues from product sales where marketed and from partnerships, milestone and licensing arrangements, while relying on ongoing clinical development, regulatory filings and capital markets financing to advance its pipeline and expand geographic reach.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

47.1%1Y

90.4%3Y

0.27%5Y

Performance

52.6%1Y

54.6%3Y

65.9%5Y

Volatility

244 M

Market cap (USD)

78,002

Daily traded volume (Shares)

12.7 / 11.56

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

5.00

1 votes

Performance:

5.00

Innovation:

5.00

Society:

5.00

Nature:

5.00

Luba Schoenig

Switzerland, 20 Mar 2025

Ein top innovatives Unternehmen, das sich auf die Behandlung von DMD spezialisiert und seine Marktstellung kontinuierlich ausbaut

EQUITIES OF THE SAME SECTOR

Braze Inc

Braze Inc Valor: 114489781

Annual Return

-50%0%+50%

Risk level

110

-0.90%USD 25.42

Veracyte Inc

Veracyte Inc Valor: 22423969

Annual Return

-50%0%+50%

Risk level

110

3.67%USD 45.81

Mobileye Global Inc

Mobileye Global Inc Valor: 122239832

Annual Return

-50%0%+50%

Risk level

110

0.95%USD 7.42

Hyrican Informationssysteme AG

Hyrican Informationssysteme AG Valor: 1094755

Annual Return

-50%0%+50%

Risk level

110

0.00%EUR 5.20

plenum AG

plenum AG Valor: 29187745

Annual Return

-50%0%+50%

Risk level

110

-3.64%EUR 2.12

CPU Softwarehouse AG

CPU Softwarehouse AG Valor: 4924656

Annual Return

-50%0%+50%

Risk level

110

-10.63%EUR 0.29

Schneider Electric SE

Schneider Electric SE Valor: 509120

Annual Return

-50%0%+50%

Risk level

110

3.55%EUR 303.00

Capgemini SE

Capgemini SE Valor: 488070

Annual Return

-50%0%+50%

Risk level

110

-2.85%EUR 108.90

LEGRAND SA

LEGRAND SA Valor: 2501522

Annual Return

-50%0%+50%

Risk level

110

3.43%EUR 144.55

Worldline SA

Worldline SA Valor: 24715654

Annual Return

-50%0%+50%

Risk level

110

-2.31%EUR 10.47

SIX

FactSet

Clearbit

Logos provided by Clearbit